Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-022255
Filing Date
2025-11-13
Accepted
2025-11-13 15:39:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9702
  Complete submission text file 0001493152-25-022255.txt   11407
Mailing Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124
Business Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124 8012789769
Co-Diagnostics, Inc. (Subject) CIK: 0001692415 (see all company filings)

EIN.: 462609396 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90782 | Film No.: 251477959
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880
Business Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880 646-793-9056
Ayrton Capital LLC (Filed by) CIK: 0001698148 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G